This Week in Cardiology

Medscape
undefined
Feb 2, 2024 • 28min

Feb 02 2024 This Week in Cardiology

FDA approves PFA for AF ablation, flawed comparisons of TEER vs MV surgery and PCI vs CABG, and cardiologists struggling with board exams are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. PFA FDA Okays Boston Scientific PFA System for Paroxysmal AF https://www.medscape.com/viewarticle/fda-okays-boston-scientific-pfa-system-paroxysmal-af-2024a1000275 Pulsed-Field Ablation for AF: The Promise and the Reality https://www.medscape.com/viewarticle/995675 ADVENT Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2307291 EU-PORIA Registry https://doi.org/10.1093/europace/euad185 Tomlinson/Mandrola Editorial https://www.jacc.org/doi/10.1016/j.jacc.2020.07.032 II. TEER vs MV Surgery EHJ Paper https://doi.org/10.1093/eurheartj/ehae046 III. ISCHEMIA Post-Hoc Studies JACC Post-Hoc ISCHEMIA Trialhttps://doi.org/10.1016/j.jacc.2023.11.002 Main ISCHEMIA paper https://www.nejm.org/doi/full/10.1056/nejmoa1915922 FAME 3 https://www.nejm.org/doi/full/10.1056/NEJMoa2112299 IV. Board Exams More Cardiologists Failing the Boards, Why and How to Fix? https://www.medscape.com/viewarticle/more-cardiologists-failing-boards-why-and-how-fix-2024a10001oi You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net
undefined
Jan 26, 2024 • 30min

Jan 26 2024 This Week in Cardiology

LAAO, more evidence that stable CAD is stable, CRT benefit over the long-term, and AF monitoring after stroke are the topics John Mandrola, MD, covers in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. LAAO This Week in Cardiology Podcast, Dec 15, 2023 https://www.medscape.com/viewarticle/999282 European Heart Journal paper https://academic.oup.com/eurheartj/article/45/3/214/7471675 LAAOS 3 https://www.nejm.org/doi/full/10.1056/NEJMoa2101897 II. CAD after Transcatheter Aortic Valve Implantation Cleveland Clinic Observational study https://doi.org/10.1093/eurheartj/ehae019 ACTIVATION trial  https://doi.org/10.1016/j.jcin.2021.06.041 III. Cardiac Resynchronization Therapy Original RAFT 2010 https://www.nejm.org/doi/full/10.1056/nejmoa1009540 Long-term RAFT  https://www.nejm.org/doi/full/10.1056/NEJMoa2304542 Editorial https://www.nejm.org/doi/full/10.1056/NEJMe2312419 IV. AF Monitoring After Stroke Japanese Observational Study https://www.ahajournals.org/doi/10.1161/JAHA.123.031508 ARTESIA https://www.nejm.org/doi/full/10.1056/NEJMoa2310234 NOAH https://www.nejm.org/doi/full/10.1056/NEJMoa2303062 LOOP substudy https://jamanetwork.com/journals/jamaneurology/fullarticle/2795865 CRYSTAL AF https://www.nejm.org/doi/full/10.1056/nejmoa1313600 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.net
undefined
Jan 19, 2024 • 30min

Jan 19 2024 This Week in Cardiology

Listener feedback on antiplatelet therapy after PCI, efficacy of bempedoic acid, off-label PFO closure, and the benefits of palliative care are discussed in this week's podcast. The topics cover recent studies, analysis, and perceptions in cardiology, providing valuable insights for healthcare professionals.
undefined
Jan 12, 2024 • 27min

Jan 12 2024 This Week in Cardiology

Topics in this podcast include GLP-1s and BaroStim Neo, a new drug for transthyretin amyloid CM, clopidogrel vs ASA years after PCI and stent, and statin use. The podcast also discusses listener feedback on obesity, the tension between regulation and innovation in cardiology, evidence generation, and the efficacy of different medications for heart conditions.
undefined
Jan 5, 2024 • 25min

Jan 05 2024 This Week in Cardiology

Neuro-modulation in HF, private equity owned hospitals, HCM, SCD and ICD re-evaluated, and peer review are the topics John Mandrola, MD, discusses in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I. Neuromodulation for HFrEF FDA Expands Label for CVRx Barostim System in HF https://www.medscape.com/viewarticle/fda-expands-label-cvrx-barostim-system-hf-2023a1000wsx BeAT HF trial https://doi.org/10.1016/j.jacc.2020.05.015 II. Private Equity Takeover of US Hospitals Hospital Adverse Events Rise After Private Equity Acquisition https://www.medscape.com/viewarticle/hospital-adverse-events-rise-after-private-equity-2023a1000wya Changes in Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition: https://jamanetwork.com/journals/jama/article-abstract/2813379 RSS audio: https://bi.medscape.com/pi/editorial/studio/audio/2024/core/999557.mp3 III. Hypertrophic Cardiomyopathy Positive Topline Results for SEQUOIA-HCM Trial in OHCM https://www.medscape.com/viewarticle/positive-topline-results-sequoia-hcm-trial-ohcm-2023a1000wu9 IV. The ICD gets a ReLook Study to Examine Routine ICD Implantation Post Heart Attack https://www.medscape.com/viewarticle/study-examine-routine-icd-implantation-post-heart-attack-2023a1000wmd PROFID Site https://profid-project.eu/profid-ehra-trial/ Declining Risk of Sudden Death in Heart Failure https://www.nejm.org/doi/full/10.1056/NEJMoa1609758 V. Peer Review Prevalence of Short Peer Reviews in 3 Leading General Medical Journals -- https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2812883 You may also like: The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington Questions or feedback, please contact news@medscape.n
undefined
Dec 15, 2023 • 29min

Dec 15 2023 This Week in Cardiology

FDA approves PFA for AF, breakthrough in PAH treatment, residual leaks after LAAO, OAC in low to intermediate risk individuals discussed in this week's cardiology podcast.
undefined
Dec 8, 2023 • 28min

Dec 08 2023 This Week in Cardiology

This podcast discusses the recent AFib guideline documents, a potential new treatment for POTS, and challenges in treating certain patient populations. It highlights the findings and limitations of trials on ablation and left atrial appendage occlusion. The speaker raises concerns about a preventive procedure and introduces a small study on transcutaneous vagus nerve stimulation for POTS with promising results.
undefined
Dec 1, 2023 • 28min

Dec 01 2023 This Week in Cardiology

Cardiology expert, Dr. John Mandrola, discusses various topics including SGLT2 inhibitors for post-MI patients, blood transfusion strategies in acute MI, Factor XI inhibitors in AF, and FDA approval of a renal denervation device. The podcast provides insights into the latest research, trial outcomes, and implications for clinical practice.
undefined
Nov 17, 2023 • 26min

Nov 17 2023 This Week in Cardiology

Dr. John Mandrola reviews the SELECT, ORBITA2, and ARTESIA trials in this week's podcast. Topics include the potential of semaglutide in reducing CVD risk, the significance of the Orbita II trial in interventional cardiology, and the management of subclinical A-fib with anticoagulation therapy.
undefined
Nov 10, 2023 • 24min

Nov 10 2023 This Week in Cardiology

Topics discussed in this podcast include renal denervation for hypertension, the risk of deadly decisions in the emergency department, FDA approval of Tirzepatide for obesity treatment, and a preview of major trials at the American Heart Association conference.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app